Congo Receives 16,000+ Ebola Vaccine Doses as Outbreak Accelerates
The Democratic Republic of the Congo (DRC) has received more than 16,000 doses of the Ervebo vaccine against Ebola, as the country grapples with the fastest-growing outbreak in its history, according to the country's health minister.
The 16,250 doses arrived at N'djili International Airport in the capital, Kinshasa, late Friday. They are the first of 70,000 doses expected from the World Health Organization (WHO) and partners, announced Thursday. More doses are expected early next week.
The current outbreak is caused by the rare Bundibugyo strain of the Ebola virus, which currently has no approved treatment or vaccine. The strain can spread easily and go undetected because some symptoms are similar to other illnesses, such as malaria.
The Ervebo vaccine is licensed to treat the Zaire strain of Ebola and has been effective in past outbreaks. However, the WHO said it may provide some protection against the Bundibugyo strain.
The latest outbreak has recorded 2,557 deaths out of 5,375 confirmed cases across six affected provinces. It is spreading at an unprecedented rate and is on track to surpass the deadliest Ebola outbreak on record, which killed more than 11,000 people across West Africa between 2014 and 2016.
Data from the Africa Centres for Disease Control and Prevention shows that transmission has not yet peaked and could reach three times its current rate.
Efforts to contain the outbreak have been hampered by armed conflict between the government and rebel groups, which control key cities in Ebola hot spots; attacks on medical personnel and facilities; an itinerant labor population and people displaced by the conflict; and a lack of crucial infrastructure.